At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
vagal nerve stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Outcomes of Treatment With Vagal Nerve Stimulation in Post-COVID Syndrome: A Pilot Study
In Brief
A clinical study evaluating vagal nerve stimulator for Post COVID Syndrome and 2 related conditions. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost COVID Syndrome, Fatigue, Headache
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJul 2022
Enrollment StartDec 2022
Primary CompletionMar 2024
TodayJul 2026
First PostedJul 6, 2022
Enrollment StartDec 21, 2022
Primary CompletionMar 28, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.0 years ago
Interventions
vagal nerve stimulatordevice
Non-invasive vagus nerve stimulator